Literature DB >> 12642279

Dose dependence of the growth rate of multicellular tumour spheroids after irradiation.

D Guirado1, M Aranda, M Vilches, M Villalobos, A M Lallena.   

Abstract

The present study investigated differences in the growth rate of multicellular tumour spheroids of the MCF-7 line of human breast cancer before and after their irradiation. Growth of the spheroids was analysed according to a model based on a Gompertz function. In this model, normalization to a common initial volume is achieved in a way that enables meaningful comparisons to be made between the results obtained for each spheroid. For irradiated spheroids the model includes an additional term to take account of sterilized cells. We found that the growth rate observed before irradiation is not fully recovered by irradiated spheroids and that growth recovery reduces with higher irradiation doses. Surviving fractions obtained at doses below 3 Gy are comparable with those found in clonogenic assays on spheroids of the same cellular line. At larger doses, discrepancies between the different studies are considerable.

Entities:  

Mesh:

Year:  2003        PMID: 12642279     DOI: 10.1259/bjr/30772617

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  3 in total

1.  Gain in cellular organization of inflammatory breast cancer: A 3D in vitro model that mimics the in vivo metastasis.

Authors:  Jorge Morales; Mary L Alpaugh
Journal:  BMC Cancer       Date:  2009-12-23       Impact factor: 4.430

2.  Low-dose radiation hyper-radiosensitivity in multicellular tumour spheroids.

Authors:  D Guirado; M Aranda; M Ortiz; J A Mesa; L I Zamora; E Amaya; M Villalobos; A M Lallena
Journal:  Br J Radiol       Date:  2012-10       Impact factor: 3.039

3.  In vivo demonstration of enhanced radiotherapy using rare earth doped titania nanoparticles.

Authors:  Helen E Townley; Jeewon Kim; Peter J Dobson
Journal:  Nanoscale       Date:  2012-07-06       Impact factor: 7.790

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.